ALPHA MEN'S CLINIC Trademark
Trademark Overview
On Tuesday, October 17, 2023, a trademark application was filed for ALPHA MEN'S CLINIC with the United States Patent and Trademark Office. The USPTO has given the ALPHA MEN'S CLINIC trademark a serial number of 98227294. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, June 4, 2024. The ALPHA MEN'S CLINIC trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Health care services, namely, hormone replacement therapy
General Information
Serial Number | 98227294 |
Word Mark | ALPHA MEN'S CLINIC |
Filing Date | Tuesday, October 17, 2023 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Tuesday, June 4, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Health care services, namely, hormone replacement therapy |
Classification Information
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, October 24, 2023 |
Primary Code | 044 |
First Use Anywhere Date | Friday, September 22, 2023 |
First Use In Commerce Date | Friday, September 22, 2023 |
Trademark Owner History
Party Name | NOT AVAILABLE |
Party Type | 10 - Original Applicant |
Legal Entity Type | 01 - Individual |
Address | oklahoma city, OK 73120 |
Trademark Events
Event Date | Event Description |
Tuesday, October 24, 2023 | NEW APPLICATION ENTERED |
Tuesday, October 24, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, June 3, 2024 | ASSIGNED TO EXAMINER |
Tuesday, June 4, 2024 | NON-FINAL ACTION E-MAILED |
Tuesday, June 4, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, June 4, 2024 | NON-FINAL ACTION WRITTEN |